phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Updated KDIGO Guideline Recommends More Personalized Treatment for Anemia in Chronic Kidney Disease

The 2026 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) calls for a more individualized approach to treatment, including tailored decisions on when to start anemia medications and preferred use of intravenous iron for patients receiving hemodialysis. A synopsis of the guideline highlighting the primary recommendations regarding the use of iron, erythropoiesis-stimulating agents (ESAs), and hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHI) is published in Annals of Internal Medicine.

September 14, 2026


September 21 2026

September 18 2026

September 17 2026

September 16 2026

September 15 2026

September 14 2026

September 11 2026

September 10 2026

September 9 2026

September 8 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy